Orally Administrated Cinnamon Extract Reduces β-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models
2011

Cinnamon Extract Reduces Amyloid Oligomerization and Improves Cognitive Impairment in Alzheimer's Disease Models

publication Evidence: high

Author Information

Author(s): Frydman-Marom Anat, Levin Aviad, Farfara Dorit, Benromano Tali, Scherzer-Attali Roni, Peled Sivan, Vassar Robert, Segal Daniel, Gazit Ehud, Frenkel Dan, Ovadia Michael

Primary Institution: Tel Aviv University

Hypothesis

Can cinnamon extract inhibit the formation of toxic amyloid oligomers and improve cognitive function in Alzheimer's disease models?

Conclusion

Cinnamon extract significantly reduces toxic amyloid oligomers and improves cognitive behavior in Alzheimer's disease animal models.

Supporting Evidence

  • Cinnamon extract inhibited the formation of toxic Aβ oligomers in vitro.
  • Oral administration of cinnamon extract improved cognitive behavior in AD transgenic mice.
  • Cinnamon extract rectified reduced longevity and locomotion defects in AD fly models.
  • CEppt treatment led to a significant reduction in the level of toxic Aβ oligomers in mouse brains.

Takeaway

Cinnamon extract can help make the brain healthier by stopping bad proteins from forming and helping memory in mice with Alzheimer's.

Methodology

The study used in vitro and in vivo models, including Drosophila and transgenic mice, to test the effects of cinnamon extract on amyloid oligomerization and cognitive function.

Limitations

The mechanism of action of cinnamon extract was not fully elucidated, and its ability to cross the blood-brain barrier was not tested.

Statistical Information

P-Value

p<0.034

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016564

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication